These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
128 related articles for article (PubMed ID: 9805186)
1. Cyclophosphamide therapy in a patient with membranoproliferative glomerulonephritis and essential mixed cryoglobulinaemia. Abu-Shakra M; Hausmann MJ; Kachko L; Flusser D; Buskila D; Sukenik S Clin Rheumatol; 1998; 17(5):395-6. PubMed ID: 9805186 [No Abstract] [Full Text] [Related]
2. Mixed cryoglobulinaemia and hepatitis C virus infection. Grandinetti F; De Paola L; Prunesti P; Mazzitello G Ital J Gastroenterol Hepatol; 1997 Dec; 29(6):579. PubMed ID: 9513839 [No Abstract] [Full Text] [Related]
3. Delayed onset of membranoproliferative glomerulonephritis in a patient with type I cryoglobulinaemia. Hent RC; Bergkamp FJ; Weening JJ; van Dorp WT Nephrol Dial Transplant; 1997 Oct; 12(10):2155-8. PubMed ID: 9351082 [No Abstract] [Full Text] [Related]
4. Successful cyclophosphamide treatment of cryoglobulinemic membranoproliferative glomerulonephritis associated with hepatitis C virus infection. Quigg RJ; Brathwaite M; Gardner DF; Gretch DR; Ruddy S Am J Kidney Dis; 1995 May; 25(5):798-800. PubMed ID: 7747735 [TBL] [Abstract][Full Text] [Related]
5. Failure of cyclosporin therapy in type II mixed cryoglobulinemia associated with hepatitis C virus infection. Horsmans Y; Tennstedt D; Cornu C; Geubel AP Clin Exp Rheumatol; 1998; 16(4):514-5. PubMed ID: 9706447 [No Abstract] [Full Text] [Related]
6. Membranoproliferative glomerulonephritis type I, mixed cryoglobulinemia and lymphoma in the absence of hepatitis C infection. Rosas SE; Tomaszewski JE; Feldman HI; Foster MH Am J Nephrol; 1999; 19(5):599-604. PubMed ID: 10575191 [TBL] [Abstract][Full Text] [Related]
7. [Mixed cryoglobulinemia, membranoproliferative glomerulonephritis, and chronic hepatitis C. Sequential treatment with immunosuppressors and interferon]. Millán Mon A; Chahin J; Romero F; Perera A Med Clin (Barc); 1994 Jan; 102(1):34-5. PubMed ID: 8133687 [No Abstract] [Full Text] [Related]
8. Interferon toxicity in hepatitis C virus-associated type II cryoglobulinemia. Di Lullo L; De Rosa FG; Coviello R; Sorgi ML; Coen G; Zorzin LR; Casato M Clin Exp Rheumatol; 1998; 16(4):506. PubMed ID: 9706438 [No Abstract] [Full Text] [Related]
9. [Interferon therapy in cryoglobulinemic membranoproliferative glomerulonephritis associated with hepatitis C]. Jakab L Orv Hetil; 1997 Jan; 138(1):43-4. PubMed ID: 9026771 [No Abstract] [Full Text] [Related]
10. [Renal involvement during type 1 cryoglobulinemia]. Zaidan M; Plasse F; Rabant M; Javaugue V; Knebelmann B; Alyanakian MA; Joly D; Nochy D; Bridoux F Nephrol Ther; 2016 Apr; 12 Suppl 1():S71-81. PubMed ID: 26972092 [TBL] [Abstract][Full Text] [Related]
11. Extranodal small lymphocyte proliferation: a case of progression to lymphocytic lymphoma. Mazzucchelli R; Andreu-Sanchez JL; Cuende E Clin Exp Rheumatol; 1999; 17(6):756-7. PubMed ID: 10609084 [No Abstract] [Full Text] [Related]
12. Successful treatment of severe/active cryoglobulinaemic membranoproliferative glomerulonephritis associated with hepatitis C virus infection by means of the sequential administration of immunosuppressive and antiviral agents. Garini G; Allegri L; Carnevali ML; Iannuzzella F; Buzio C Nephrol Dial Transplant; 2006 Nov; 21(11):3333-4. PubMed ID: 16782995 [No Abstract] [Full Text] [Related]
13. Sofosbuvir and Daclatsvir in Treatment of Hepatitis C Virus-related Membranoproliferative Glomerulonephritis With Cryoglobulinemia in a Patient With Hepatitis C Genotype 4. Elmowafy AY; El Maghrabi HM; Zahab MA; Elwasif SM; Bakr MA Iran J Kidney Dis; 2018 Nov; 12(6):382-384. PubMed ID: 30595569 [TBL] [Abstract][Full Text] [Related]
15. Mixed cryoglobulinemia and membranoproliferative glomerulonephritis associated with hepatitis C virus infection. Lopes E; Lopes LV; Silva AE Ann Intern Med; 1996 Nov; 125(9):781-2. PubMed ID: 8929026 [No Abstract] [Full Text] [Related]
16. Imatinib therapy for non-infection-related type II cryoglobulinemia with membranoproliferative glomerulonephritis. Wallace E; Fogo AB; Schulman G Am J Kidney Dis; 2012 Jan; 59(1):122-5. PubMed ID: 21982457 [TBL] [Abstract][Full Text] [Related]
17. Oral interferon-alpha treatment of mice with cryoglobulinemic glomerulonephritis. Segerer S; Hudkins KL; Taneda S; Wen M; Cui Y; Segerer M; Farr AG; Alpers CE Am J Kidney Dis; 2002 Apr; 39(4):876-88. PubMed ID: 11920357 [TBL] [Abstract][Full Text] [Related]
18. [Interferon therapy in cryoglobulinemic membranoproliferative glomerulonephritis associated with hepatitis C virus infection]. Mátyus J; Kovács J; Ujhelyi L; Kárpáti I; Dalmi L; Kakuk G Orv Hetil; 1996 Nov; 137(45):2527-30. PubMed ID: 8999399 [TBL] [Abstract][Full Text] [Related]
19. A patient presenting with isolated hematuria and renal dysfunction as rare manifestation of cryoglobulinemic glomerulonephritis in the course of autoimmune diseases including Sjögren's syndrome. Yamanaka M; Fujigaki Y; Kono H; Nagura M; Arai S; Tamura Y; Ota T; Shibata S; Kondo F; Yamaguchi Y; Uchida S CEN Case Rep; 2018 Nov; 7(2):211-216. PubMed ID: 29671215 [TBL] [Abstract][Full Text] [Related]
20. Anti-CD20 monoclonal antibody (rituximab) treatment for hepatitis C-negative therapy-resistant essential mixed cryoglobulinemia with renal and cardiac failure. Ghijsels E; Lerut E; Vanrenterghem Y; Kuypers D Am J Kidney Dis; 2004 May; 43(5):e34-8. PubMed ID: 15112197 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]